0000849146-24-000010.txt : 20240103
0000849146-24-000010.hdr.sgml : 20240103
20240103162433
ACCESSION NUMBER: 0000849146-24-000010
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240101
FILED AS OF DATE: 20240103
DATE AS OF CHANGE: 20240103
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Fife Steven R
CENTRAL INDEX KEY: 0001408954
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35647
FILM NUMBER: 24506882
MAIL ADDRESS:
STREET 1: C/O LECG 2000 POWELL STREET, STE 600
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Lifevantage Corp
CENTRAL INDEX KEY: 0000849146
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 900224471
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 3300 TRIUMPH BLVD
STREET 2: SUITE 700
CITY: LEHI
STATE: UT
ZIP: 84043
BUSINESS PHONE: 801-432-9000
MAIL ADDRESS:
STREET 1: 3300 TRIUMPH BLVD
STREET 2: SUITE 700
CITY: LEHI
STATE: UT
ZIP: 84043
FORMER COMPANY:
FORMER CONFORMED NAME: LIFELINE THERAPEUTICS, INC.
DATE OF NAME CHANGE: 20041019
FORMER COMPANY:
FORMER CONFORMED NAME: YAAK RIVER RESOURCES INC
DATE OF NAME CHANGE: 19920703
FORMER COMPANY:
FORMER CONFORMED NAME: ANDRAPLEX CORP
DATE OF NAME CHANGE: 19920406
4
1
wk-form4_1704317051.xml
FORM 4
X0508
4
2024-01-01
0
0000849146
Lifevantage Corp
LFVN
0001408954
Fife Steven R
3300 NORTH TRIUMPH BLVD #700
LEHI
UT
84043
1
1
0
0
President and CEO
0
Common Stock
2024-01-01
4
M
0
17001
0
A
648160
D
Common Stock
2024-01-01
4
M
0
3233
0
A
651393
D
Common Stock
2024-01-01
4
F
0
16550
6
D
634843
D
Performance Stock Units
2024-01-01
4
M
0
17001
0
D
Common Stock
17001
34003
D
Performance Stock Units
2024-01-01
4
M
0
3233
0
D
Common Stock
3233
9699
D
On August 18, 2022, the reporting person was granted Performance Restricted Stock Units ("PSUs") which vest only to the extent specified financial performance criteria are achieved and subject to the reporting person's continued service with the issuer, as provided in the Form 4 filed by the reporting person on August 22, 2022. The reporting person initially reported the number of shares that were eligible to be earned at target-level performance achievement. The performance criteria were achieved at a level above target. The actual number of shares that vested was 133.13% of the at-target number of shares subject to vesting on that date. The number of PSUs beneficially owned following the reported transaction has been updated to reflect the number of earned units as well as the number of earned units remaining following the cancellation of 68,006 earned units, as reported on the Form 4 filed on November 8, 2023.
On November 10, 2022, the reporting person was granted PSUs which vest only to the extent specified financial performance criteria are achieved and subject to the reporting person's continued service with the issuer, as provided in the Form 4 filed by the reporting person on November 15, 2022. The reporting person initially reported the number of shares that were eligible to be earned at target-level performance achievement. The performance criteria were achieved at a level above target. The actual number of shares that vested was 133.13% of the at-target number of shares subject to vesting on that date. The number of PSUs beneficially owned following the reported transaction has been updated to reflect the number of earned units as well as the number of earned units remaining following the cancellation of 9,700 earned units, as reported on the Form 4 filed on November 8, 2023.
These shares were withheld to satisfy tax withholding obligations in connection with the vesting of a stock unit award granted to the reporting person on August 12, 2021, a PSU award and stock unit award granted to the reporting person on August 22, 2022, and a PSU award and stock unit award granted to the reporting person on November 10, 2022.
PSUs convert into common stock on a one-for-one basis.
Alissa Neufeld, Power of Attorney for Steven R. Fife
2024-01-03